Human Papillomavirus Clinical Trial
Official title:
Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men
Studies indicate that men who have sex with men (MSM) have a high prevalence of anogenital
Human papillomavirus (HPV) infection and increased risk for HPV related anogenital lesions
including anogenital warts, anal intraepithelial neoplasia (the abnormal proliferation of
cells) and anal cancer. Currently in Australia, HPV vaccine for men is not covered by
programs. This study will explore the prevalence of HPV infection and sexual behaviours
associated with varying prevalence of HPV infection.
The investigators will survey 200 MSM aged 16-20 years who just started their sexual life.
The investigators will use a questionnaire to collect information of socio-demographic
characteristics, lifetime sexual experience, recent sexual experience, the most recent
sexual contact, sexually transmitted infections (STIs)/HIV history and testing history, HPV
knowledge and attitude, smoking/alcohol/drug/circumcision. The investigators will also
collect oral, penile and anal samples as well as blood samples to test for HPV DNA and
antibody.
The study will include four visits in the 12-month period. In each visit, participants will
be asked to fill a questionnaire and provide oral, penile and anal samples as well as blood
samples.
Study aims
The objectives of this study are to determine among younger MSM:
1. The prevalence of HPV infection
2. Sexual behaviours associated with varying prevalence of HPV infection
Methods
Criteria for eligibility:
- Men aged 16 to 20
- Same sex attracted
- Able to complete all study requirements including questionnaire in English and
completion of 4 visits
Recruitment
Men were recruited between October 2010 and September 2012 via a number of avenues focusing
on gay teenage males: community organizations supporting gay teenagers with study promotion
at social events such as dance parties; gay clubs at six Melbourne universities; gay
community events including the MidSumma Festival; gay media including radio and magazine;
the study website; and social networking websites including Facebook, Twitter and Grindr.
Recruitment also took place through three sexual health services in Melbourne.
Men were assessed by the study nurse at a baseline visit then 3, 6, and 12 months later. On
each occasion specimens were obtained for HPV DNA testing, blood was obtained for HPV
serology, and men completed a questionnaire regarding their sexual experiences.
Specimen collection Specimens were obtained from men for HPV DNA testing in the following
order: first an oral rinse, second an anal canal swab, third a perianal swab, then fourth a
penile swab. The oral rinse and penile swab were self-collected by men after watching a
video demonstrating how to self-collect these specimens
Men were screened for pharyngeal and rectal Neisseria gonorrhoeae using modified
Thayer-martin media. First void urine and a rectal swab were tested for Chlamydia
trachomatis by strand displacement assay (Becton Dickinson ProbeTec ET, NJ, USA). In
addition, men were screened for syphilis using enzyme immunoassay (EIA) and rapid plasma
reagin and tested for HIV using EIA.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02740790 -
Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
|
Phase 2 | |
Completed |
NCT01845779 -
Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal
|
N/A | |
Completed |
NCT02808832 -
An HPV Vaccine Provider Intervention in Safety Net Clinics
|
N/A | |
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A | |
Completed |
NCT01456715 -
Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.
|
Phase 3 | |
Completed |
NCT02968420 -
Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine
|
Phase 4 | |
Completed |
NCT02007421 -
Study of the Prevention of Anal Cancer
|
N/A | |
Recruiting |
NCT04708470 -
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
|
Phase 1/Phase 2 | |
Completed |
NCT02267876 -
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
|
||
Recruiting |
NCT01459289 -
Psychosocial Effect of HPV Positivity
|
N/A | |
Completed |
NCT01358097 -
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
|
N/A | |
Completed |
NCT01342978 -
Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
|
N/A | |
Not yet recruiting |
NCT06434337 -
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
|
||
Active, not recruiting |
NCT02576561 -
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
|
Phase 2 | |
Terminated |
NCT02503111 -
The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men
|
N/A | |
Recruiting |
NCT02126189 -
The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
|
N/A | |
Completed |
NCT01766284 -
Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix
|
N/A | |
Completed |
NCT01524003 -
Chinese Cancer Prevention Study(CHICAPS)
|
N/A | |
Recruiting |
NCT05026138 -
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
|
||
Recruiting |
NCT03742869 -
HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma
|